Research2Guidance October 14, 2021
The Digital Decentralized Clinical Trial (DDCT) Solution Market will grow significantly to reach $9.13 billion in 2026.
The market for DDCT technologies will grow by 38.5% (CAGR) to reach 9.13 billion USD in 2026. While the pandemic propelled the market forward, it’s proposed benefits and increased efficiencies to research activities ensures it is here to stay. A new report by R2G discusses the market.
Digital solutions for decentralized clinical trials allow some or all clinical trial activities to be virtualized, rather than conducted in person out of traditional trial sites. DDCT technologies provide trial sponsors (organizations such as pharmaceutical companies running clinical trials) wearables to continuously collect patient data, telemedicine to deliver education and consent, and software dashboards to track...